{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:49:40Z","timestamp":1753890580877,"version":"3.41.2"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Lipidomics is emerging for biomarker discovery in cardiovascular disease, and circulating lipids are increasingly incorporated in risk models to predict cardiovascular events. Moreover, specific classes of lipids, such as sphingomyelins, ceramides, and triglycerides, have been related to coronary artery disease (CAD) severity and plaque characteristics. To avoid unnecessary testing, it is important to identify individuals at low CAD risk. The only pretest model available so far to rule out the presence of coronary atherosclerosis in patients with chest pain, but normal coronary arteries, is the minimal risk tool (MRT).<\/jats:p><jats:p><jats:bold>Aim:<\/jats:bold> Using state-of-the-art statistical methods, we aim to verify the additive predictive value of a set of lipids, derived from targeted plasma lipidomics of suspected CAD patients, to a re-estimated version of the MRT for ruling out the presence of coronary atherosclerosis assessed by coronary CT angiography (CCTA).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Two hundred and fifty-six subjects with suspected stable CAD recruited from five European countries within H2020-SMARTool, undergoing CCTA and blood sampling for clinical biochemistry and lipidomics, were selected. The MRT was validated by regression methods and then re-estimated (reMRT). The reMRT was used as a baseline model in a likelihood ratio test approach to assess the added predictive value of each lipid from 13 among ceramides, triglycerides, and sphingomyelins. Except for one lipid, the analysis was carried out on more than 240 subjects for each lipid. A sensitivity analysis was carried out by considering two alternative models developed on the cohort as baseline models.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In 205 subjects, coronary atherosclerosis ranged from minimal lesions to overt obstructive CAD, while in 51 subjects (19.9%) the coronary arteries were intact. Four triglycerides and seven sphingomyelins were significantly (<jats:italic>p<\/jats:italic> &amp;lt; 0.05) and differentially expressed in the two groups and, at a lesser extent, one ceramide (<jats:italic>p<\/jats:italic> = 0.067). The probability of being at minimal risk was significantly better estimated by adding either Cer(d18:1\/16:0) (<jats:italic>p<\/jats:italic> = 0.01), SM(40:2) (<jats:italic>p<\/jats:italic> = 0.04), or SM(41:1) at a lesser extent (<jats:italic>p<\/jats:italic> = 0.052) to reMRT than by applying the reMRT alone. The sensitivity analysis confirmed the relevance of these lipids. Furthermore, the addition of SM(34:1), SM(38:2), SM(41:2), and SM(42:4) improved the predictive performance of at least one of the other baseline models. None of the selected triglycerides was found to provide an added value.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Plasma lipidomics can be a promising source of diagnostic and prognostic biomarkers in cardiovascular disease, exploitable not only to assess the risk of adverse events but also to identify subjects without coronary atherosclerosis, thus reducing unnecessary further testing in normal subjects.<\/jats:p>","DOI":"10.3389\/fcvm.2021.682785","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T09:50:51Z","timestamp":1626429051000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictive Added Value of Selected Plasma Lipids to a Re-estimated Minimal Risk Tool"],"prefix":"10.3389","volume":"8","author":[{"given":"Antonella","family":"Bodini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Di Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Signore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Neglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J.H.A.","family":"Scholte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierpaolo","family":"Mincarone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo G.","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gualtiero","family":"Pelosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Rocchiccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"ESC Scientific Document Group, 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1093\/eurheartj\/ehy267","article-title":"The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability","volume":"39","author":"Knuuti","year":"2018","journal-title":"Eur Heart J."},{"key":"B3","first-page":"1","article-title":"Validated models for pre-test probability of stable coronary artery disease: a systematic review suggesting how to improve validation procedures","volume-title":"BMJ Open.","author":"Mincarone","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1001\/jamacardio.2016.5501","article-title":"Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Investigators. Identification of patients with stable chest pain deriving minimal value from noninvasive testing: the PROMISE minimal-risk tool, a secondary analysis of a randomized clinical trial","volume":"2","author":"Fordyce","year":"2017","journal-title":"JAMA Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijcard.2017.09.033","article-title":"Identification of patients with stable chest pain deriving minimal value from coronary computed tomography angiography: an external validation of the PROMISE minimal-risk tool","volume":"252","author":"Adamson","year":"2018","journal-title":"Int J Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s10554-020-01982-7","article-title":"Validation and update of the minimal risk tool in patients suspected of chronic coronary syndrome","volume":"20","author":"Rasmussen","year":"2020","journal-title":"Int J Cardiovasc Imaging."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular Metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11883-010-0110-y","article-title":"Lipidomics: a tool for studies of atherosclerosis","volume":"12","author":"Ekroos","year":"2010","journal-title":"Curr Atheroscler Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diabet.2019.07.006","article-title":"Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography","volume":"46","author":"Mantovani","year":"2020","journal-title":"Diabetes Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI131838","article-title":"Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease","volume":"130","author":"Poss","year":"2020","journal-title":"J Clin Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/metabo10040163","article-title":"A review of lipidomics of cardiovascular disease highlights the importance of isolating lipoproteins","volume":"10","author":"Ding","year":"2020","journal-title":"Metabolites."},{"key":"B13","doi-asserted-by":"publisher","first-page":"12899","DOI":"10.1038\/s41598-021-92339-0","article-title":"Lipid profile in statin users with coronary artery disease annotated by Coronary Computed Tomography Angiography","volume":"11","author":"Michelucci","year":"2021","journal-title":"Nat Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1373\/clinchem.2012.182550","article-title":"Bossuyt PMM. Quantifying the added value of a diagnostic test or marker","volume":"58","author":"Moons","year":"2012","journal-title":"Clin Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jama.2019.21667","article-title":"Do polygenic risk scores improve patient selection for prevention of coronary artery disease?","volume":"323","author":"Khan","year":"2020","journal-title":"JAMA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41512-018-0037-2","article-title":"Quantifying the added value of new biomarkers: how and how not","volume":"2","author":"Cook","year":"2018","journal-title":"Diagn Progn Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM197906143002402","article-title":"Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease","volume":"300","author":"Diamond","year":"1979","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/ATVBAHA.115.306818","article-title":"Effect of coronary atherosclerosis and myocardial ischemia on plasma levels of high-sensitivity troponin T and NT-proBNP in patients with stable angina","volume":"36","author":"Caselli","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-925864849-5","article-title":"simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/01.CIR.51.4.5","article-title":"A reporting system on patients evaluated for coronary artery disease report of the ad hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery","volume":"51","author":"Austen","year":"1975","journal-title":"Am Heart Assoc Circul."},{"key":"B22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jcct.2016.04.005","article-title":"CAD-RADS(TM) coronary artery disease - reporting and data system. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI) Endorsed by the American College of Cardiology","volume":"10","author":"Cury","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"B23","unstructured":"ViennaR Foundation for Statistical ComputingR: A Language and Environment for Statistical Computing2018"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/eurheartj\/ehr014","article-title":"A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension","volume":"32","author":"Genders","year":"2011","journal-title":"Eur Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-11-13","article-title":"One statistical test is sufficient for assessing new predictive markers","volume":"11","author":"Vickers","year":"2011","journal-title":"BMC Med Res Methodol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/sim.5727","article-title":"Testing for improvement in prediction model performance","volume":"32","author":"Pepe","year":"2013","journal-title":"Stat Med."},{"key":"B27","unstructured":"710\n            ZeileisA\n            HothornT\n          Diagnostic Checking in Regression Relationships2002"},{"key":"B28","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/hrt.2010.193201","article-title":"Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque","volume":"97","author":"Korosoglou","year":"2011","journal-title":"Heart."},{"key":"B29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2174\/1389201018666170630120805","article-title":"Biomarkers in stable coronary artery disease","volume":"18","author":"Rusnak","year":"2017","journal-title":"Curr Pharm Biotechnol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","article-title":"Cardiac troponin T and troponin I in the general population","volume":"139","author":"Welsh","year":"2019","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.cjca.2019.08.022","article-title":"Variability in high-sensitivity cardiac troponin T testing in stable patients with and without coronary artery disease","volume":"35","author":"Brophy","year":"2019","journal-title":"Can J Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12944-020-01329-0","article-title":"Association between ceramides and coronary artery stenosis in patients with coronary artery disease","volume":"19","author":"Tu","year":"2020","journal-title":"Lipids Health Dis."},{"key":"B33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2000"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1002\/sim.7041","article-title":"Net reclassification index at event rate: properties and relationships","volume":"36","author":"Pencina","year":"2017","journal-title":"Statist Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e017408","DOI":"10.1161\/JAHA.120.017408","article-title":"Cardiac noninvasive diagnostic testing for outpatient chest pain: rethinking \u201cless is more\u201d","volume":"9","author":"Butala","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"k504","DOI":"10.1136\/bmj.k504","article-title":"Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials","volume":"360","author":"Siontis George","year":"2018","journal-title":"BMJ."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e015724","DOI":"10.1161\/JAHA.119.015724","article-title":"Clinical effectiveness of cardiac noninvasive diagnostic testing in outpatients evaluated for stable coronary artery disease","volume":"9","author":"Roifman","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e3485","DOI":"10.1136\/bmj.e4476","article-title":"Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts","volume":"344","author":"Genders","year":"2012","journal-title":"BMJ."},{"key":"B39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.116.023396","article-title":"European society of cardiology-recommended coronary artery disease consortium pretest probability scores more accurately predict obstructive coronary disease and cardiovascular events than the diamond and forrester score: the partners registry","volume":"134","author":"Bittencourt","year":"2016","journal-title":"Circulation."},{"key":"B40","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/MCA.0000000000000696","article-title":"Impact of sex-specific differences in calculating the pretest probability of obstructive coronary artery disease in symptomatic patients: a coronary computed tomographic angiography study","volume":"30","author":"Zhang","year":"2019","journal-title":"Coron Artery Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"ehaa946.1376","DOI":"10.1093\/ehjci\/ehaa946.1376","article-title":"Combining minimal risk stratification and prediction of obstructive CAD \u2013 clinical utility of a dual pre-test probability model","volume":"41","author":"Rasmussen","year":"2020","journal-title":"Eur Heart J."},{"key":"B42","first-page":"95","volume-title":"Subset selection in regression \/ Alan Miller","author":"Miller","year":""},{"key":"B43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1198\/016214504000000269","article-title":"Methods and criteria for model selection","volume":"99","author":"Kadane","year":"2004","journal-title":"J Am Statist Assoc"},{"key":"B44","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/ehjci\/jeu033","article-title":"Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease","volume":"15","author":"Ellims","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-015-0053-y","article-title":"Sphingolipids in cardiovascular diseases and metabolic disorders","volume":"14","author":"Borodzicz","year":"2015","journal-title":"Lipids Health Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.3390\/ijms14047716","article-title":"Sphingomyelin in high-density lipoproteins: structural role and biological function","volume":"14","author":"Mart\u00ednez-Beamonte","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"296417","DOI":"10.1155\/2015\/296417","article-title":"Dysfunctional high-density lipoprotein: an innovative target for proteomics and lipidomics","volume":"2015","author":"Salazar","year":"2015","journal-title":"Cholesterol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0022-227532007-1","article-title":"Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins","volume":"41","author":"Pruzanski","year":"2000","journal-title":"J Lipid Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1161\/CIRCULATIONAHA.107.182615","article-title":"American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology","volume":"115","author":"Alexander","year":"2007","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1161\/CIRCULATIONAHA.107.182616","article-title":"American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology","volume":"115","author":"Alexander","year":"2007","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e014467","DOI":"10.1136\/bmjopen-2016-014467","article-title":"External validation and extension of a diagnostic model for obstructive coronary artery disease: a cross-sectional predictive evaluation in 4,888 patients of the Austrian Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort","volume":"7","author":"Edlinger","year":"2017","journal-title":"BMJ Open."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamacardio.2020.2996","article-title":"Clinically important improvements in risk assessment by adding high-sensitivity troponin level to cholesterol guidelines","volume":"5","author":"White","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"method of comparing the areas under Receiver Operating Characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.682785\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T09:51:02Z","timestamp":1626429062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.682785\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":54,"alternative-id":["10.3389\/fcvm.2021.682785"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.682785","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"article-number":"682785"}}